AbbVie Inc. is a major biopharmaceutical company that develops and sells prescription medicines. Its disclosed lobbying focuses on health-related matters like drug pricing, access, and patent issues, and on international and domestic tax rules. Filings show it spent about $240,000 and used Cornerstone Government Affairs.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
JOHN CRUMBLISS
The latest disclosures for this client.
CORNERSTONE GOVERNMENT AFFAIRS, INC.
Q1CORNERSTONE GOVERNMENT AFFAIRS, INC.
Q4The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
CORNERSTONE GOVERNMENT AFFAIRS, INC.
JOHN SANDELL
CORNERSTONE GOVERNMENT AFFAIRS, INC.
MICHAEL GOODMAN
CORNERSTONE GOVERNMENT AFFAIRS, INC.
STACY RICH
CORNERSTONE GOVERNMENT AFFAIRS, INC.
TODD WEBSTER
CORNERSTONE GOVERNMENT AFFAIRS, INC.
CORNERSTONE GOVERNMENT AFFAIRS, INC.
Q3CORNERSTONE GOVERNMENT AFFAIRS, INC.
Q2CORNERSTONE GOVERNMENT AFFAIRS, INC.
Q1